Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jul 23, 2012
For more info, visit http://www.bio-rad.com/yt/3/ProteinIn.... There are many important processes that need to be understood when developing new drugs. Measuring the binding of small molecule drugs to liposomes is crucial when estimating the intestinal absorptivity of new drugs. The mechanism of action of drug peptides on liposomes and lipid bilayers is essential when recommending drug dosages. In this webinar we will present our latest unpublished data, showing how the new ProteOn™ lipid capturing kits from Bio-Rad have been used to address these key drug development issues.
Presenter: Dalia Shezifi, PhD Applications Manager Bio-Rad Haifa Israel
Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.